title: Defining the optimal activated clotting times during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.
authors.forename: G
authors.initials: G
authors.lastname: Helft
authors.forename: F
authors.initials: F
authors.lastname: Beygui
authors.forename: C
authors.initials: C
authors.lastname: le Feuvre
authors.forename: J P
authors.initials: JP
authors.lastname: Metzger
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D001777:Blood Coagulation / Q000187:drug effects; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D023381:Endpoint Determination / Q000706:statistics & numerical data; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012306:Risk; D014914:Whole Blood Coagulation Time
chemical_list: D006493:Heparin